IL-6, a critical pathogenic cytokine in several inflammatory diseases, including IBD (73), enhances intestinal epithelial permeability by impairing TJs integrity and downregulating E-cadherin expression (51, 74, 75). This evidence concerns the gene IL6 and inflammatory bowel disease.